Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Production & Manufacturing
Manufacturing
Return to: PBR Home | Production & Manufacturing | Manufacturing | News
Search Refinements

Manufacturing News

View news from other Pharmaceutical sectors:
121-135 of 2208 results
Mylan announces US launch of Generic Lopressor Tablets 37.5 mg and 75 mg
Mylan announced the U.S. launch of Metoprolol Tartrate Tablets USP, 37.5 mg and 75 mg, which is the generic version of Novartis' Lopressor Tablets.
Production & Manufacturing > Manufacturing > News
Recipharm acquires majority stake in Nitin Lifesciences
Recipharm AB has completed the acquisition of a majority stake in Nitin Lifesciences Limited (“Nitin”), an Indian sterile injectables CMO, currently owned by the Sobti family.
Production & Manufacturing > Manufacturing > News
PharmaCyte's encapsulation facility for pancreatic cancer therapy deemed suitable by Thai FDA
PharmaCyte Biotech reported that the encapsulation facility located in Bangkok, Thailand, that will be used to encapsulate the live cells used for PharmaCyte’s pancreatic cancer therapy has recently been inspected by the Food and Drug Administration of Thailand (Thai FDA).
Production & Manufacturing > Manufacturing > News
Pfizer terminates $160bn merger with Allergan
By PBR Staff Writer
Pfizer has terminated its $160bn merger with Allergan, after the US Government took new steps to bring an end to tax inversion agreements.
Production & Manufacturing > Manufacturing > News
Gilead Sciences to acquire Nimbus Apollo in $1.2bn deal
By PBR Staff Writer
Gilead Sciences has agreed to acquire Nimbus Therapeutics' subsidiary Nimbus Apollo and its Acetyl-CoA Carboxylase (ACC) inhibitor program in a transaction valued at up to $1.2bn.
Production & Manufacturing > Manufacturing > News
FTC seeks additional data on $160bn Pfizer-Allergan merger
By PBR Staff Writer
The US Federal Trade Commission (FTC) has requested additional information from Pfizer and Allergan on their proposed $160bn merger deal.
Production & Manufacturing > Manufacturing > News
Ariad Pharmaceuticals to cut 25% of headquarter positions
ARIAD Pharmaceuticals is reducing approximately 25% of its headquarter positions.
Production & Manufacturing > Manufacturing > News
Shire wins patent trial against Allergan in Lialda patent case in US
By PBR Staff Writer
A US district court ruled in favor of Shire Plc, preventing Allergan from selling generic versions of the ulcerative colitis drug, Lialda, until 2020.
Production & Manufacturing > Manufacturing > News
Onxeo acquires DNA Therapeutics
By PBR Staff Writer
Onxeo has acquired DNA Therapeutics and its signal-interfering DNA (siDNA) repair technology and lead product candidate AsiDNA.
Production & Manufacturing > Manufacturing > News
Vetter breaks ground on manufacturing facility in Germany
Vetter announced the construction of a new building at a ground breaking ceremony held at its Ravensburg Schuetzenstrasse site.
Production & Manufacturing > Manufacturing > News
Merck wins hepatitis C virus drug patent case against Gilead
By PBR Staff Writer
A federal jury in California has ruled in favor of Merck and Ionis Pharmaceuticals in a lawsuit against Gilead Sciences on hepatitis C virus (HCV) drug patent case.
Production & Manufacturing > Manufacturing > News
Helsinn, Eisai unveil revised US collaboration for CINV franchise
Helsinn, the Swiss pharmaceutical Group focused on building quality cancer care, and Eisai, the US pharmaceutical subsidiary of the research-based human healthcare company Eisai Co., have announced a revised agreement for their chemotherapy-induced nausea and vomiting (CINV) franchise.
Production & Manufacturing > Manufacturing > News
Biota Pharmaceuticals sells antibiotic assets to Spero Therapeutics
Biota Pharmaceuticals has completed the sale of assets related to its broad spectrum antibiotic program to a newly formed subsidiary of Spero Therapeutics, a Cambridge-based biopharmaceutical company founded to develop novel therapies for the treatment of bacterial infections.
Production & Manufacturing > Manufacturing > News
European Commission approves Teva's $40.5bn acquisition of Allergan's generics business
By PBR Staff Writer
The European Commission has approved Teva Pharmaceutical Industries' $40.5bn acquisition of Allergan's global generics business on the condition that the companies should sell several assets.
Production & Manufacturing > Manufacturing > News
Sanofi Pasteur, Merck plan to end joint vaccines operations in Europe
By PBR Staff Writer
Sanofi Pasteur and Merck are planning to end their joint vaccines operations in Europe.
Production & Manufacturing > Manufacturing > News
121-135 of 2208 results